MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
9 hedge funds and large institutions have $507K invested in MedAvail Holdings, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
31% less funds holding
Funds holding: 13 → 9 (-4)
31% less capital invested
Capital invested by funds: $735K → $507K (-$228K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$44K |
| 2 |
Morgan Stanley
New York
|
-$2.14K |
| 3 |
RMAM
Raab & Moskowitz Asset Management
Chatham,
New Jersey
|
-$2K |
MDVL Hedge Fund Activity: Q1 2020 in Review
9 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q1 2020, worth a combined $507K — down 31% from $735K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MDVL and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $44K sold.
- 9 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q1 2020, down from 13 in Q4 2019.
- Funds reported $507K of MedAvail Holdings, Inc. Common Stock stock for Q1 2020, down 31% quarter-over-quarter.
- 0 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of -3 holders.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q1 2020 was Citadel Advisors, an estimated $44K sold.
Based on aggregated 13F filings for Q1 2020.